Stephen R Williams1, Fang-Chi Hsu1, Keith L Keene1, Wei-Min Chen1, Godfrey Dzhivhuho1, Joe L Rowles1, Andrew M Southerland1, Karen L Furie1, Stephen S Rich1, Bradford B Worrall1, Michèle M Sale2. 1. From the Department of Biostatistical Sciences, Wake Forest School of Medicine, Winston-Salem, NC (F.C.H.); Department of Public Health Sciences (W.M.C., A.M.S., S.S.R., B.B.W., M.M.S.), Department of Neurology (S.R.W., A.M.S., B.B.W.), and Center for Public Health Genomics (W.M.C., S.S.R., B.B.W., M.M.S.), University of Virginia, Charlottesville; Department of Biology (K.L.K.) and Center for Health Disparities (K.L.K.), East Carolina University, Greenville, NC; Department of Clinical Laboratory Sciences, University of Cape Town, South Africa (G.D.); Division of Nutritional Sciences, University of Illinois at Urbana-Champaign (J.L.R.); and Rhode Island Hospital and the Alpert Medical School, Brown University, Providence (K.L.F.). 2. From the Department of Biostatistical Sciences, Wake Forest School of Medicine, Winston-Salem, NC (F.C.H.); Department of Public Health Sciences (W.M.C., A.M.S., S.S.R., B.B.W., M.M.S.), Department of Neurology (S.R.W., A.M.S., B.B.W.), and Center for Public Health Genomics (W.M.C., S.S.R., B.B.W., M.M.S.), University of Virginia, Charlottesville; Department of Biology (K.L.K.) and Center for Health Disparities (K.L.K.), East Carolina University, Greenville, NC; Department of Clinical Laboratory Sciences, University of Cape Town, South Africa (G.D.); Division of Nutritional Sciences, University of Illinois at Urbana-Champaign (J.L.R.); and Rhode Island Hospital and the Alpert Medical School, Brown University, Providence (K.L.F.). msale@virginia.edu.
Abstract
BACKGROUND AND PURPOSE: von Willebrand factor (vWF) plays an important role in thrombus formation during cerebrovascular damage. We sought to investigate the potential role of circulating vWF in recurrent cerebrovascular events and identify genetic contributors to variation in vWF level in an ischemic stroke population. METHODS: We analyzed the effect of circulating vWF on risk of recurrent stroke using survival models in the VISP trial (Vitamin Intervention for Stroke Prevention) and the use of vWF in reclassification over traditional factors. We conducted a genome-wide association study) with imputation, based on 1000 Genomes Project data, for circulating vWF levels and then interrogated loci previously associated with vWF levels. We performed expression quantitative trait locus analysis for vWF across different tissues. RESULTS:Elevated vWF levels were associated with increased risk for recurrent stroke in VISP. Adding vWF to traditional clinical parameters also improved recurrent stroke risk prediction. We identified single-nucleotide polymorphisms significantly associated with circulating vWF at the ABO locus (P<5×10-8) and replicated findings from previous genetic associations of vWF levels in humans. Expression quantitative trait locus analyses demonstrate that most associated ABO single-nucleotide polymorphisms were also associated with vWF gene expression. CONCLUSIONS:Elevated vWF levels are associated with recurrent stroke in VISP. In the VISP population, genetic determinants of vWF levels that impact vWF gene expression were identified. These data add to our knowledge of the pathophysiologic and genetic basis for recurrent stroke risk and may have implications for clinical care decision making.
RCT Entities:
BACKGROUND AND PURPOSE:von Willebrand factor (vWF) plays an important role in thrombus formation during cerebrovascular damage. We sought to investigate the potential role of circulating vWF in recurrent cerebrovascular events and identify genetic contributors to variation in vWF level in an ischemic stroke population. METHODS: We analyzed the effect of circulating vWF on risk of recurrent stroke using survival models in the VISP trial (Vitamin Intervention for Stroke Prevention) and the use of vWF in reclassification over traditional factors. We conducted a genome-wide association study) with imputation, based on 1000 Genomes Project data, for circulating vWF levels and then interrogated loci previously associated with vWF levels. We performed expression quantitative trait locus analysis for vWF across different tissues. RESULTS: Elevated vWF levels were associated with increased risk for recurrent stroke in VISP. Adding vWF to traditional clinical parameters also improved recurrent stroke risk prediction. We identified single-nucleotide polymorphisms significantly associated with circulating vWF at the ABO locus (P<5×10-8) and replicated findings from previous genetic associations of vWF levels in humans. Expression quantitative trait locus analyses demonstrate that most associated ABO single-nucleotide polymorphisms were also associated with vWF gene expression. CONCLUSIONS: Elevated vWF levels are associated with recurrent stroke in VISP. In the VISP population, genetic determinants of vWF levels that impact vWF gene expression were identified. These data add to our knowledge of the pathophysiologic and genetic basis for recurrent stroke risk and may have implications for clinical care decision making.
Authors: Nicholas L Smith; Kenneth M Rice; Edwin G Bovill; Mary Cushman; Joshua C Bis; Barbara McKnight; Thomas Lumley; Nicole L Glazer; Astrid van Hylckama Vlieg; Weihong Tang; Abbas Dehghan; David P Strachan; Christopher J O'Donnell; Jerome I Rotter; Susan R Heckbert; Bruce M Psaty; Frits R Rosendaal Journal: Blood Date: 2010-12-16 Impact factor: 22.113
Authors: Stephen R Williams; Fang-Chi Hsu; Keith L Keene; Wei-Min Chen; Sarah Nelson; Andrew M Southerland; Ebony B Madden; Bruce Coull; Stephanie M Gogarten; Karen L Furie; Godfrey Dzhivhuho; Joe L Rowles; Prachi Mehndiratta; Rainer Malik; Josée Dupuis; Honghuang Lin; Sudha Seshadri; Stephen S Rich; Michèle M Sale; Bradford B Worrall Journal: Neurology Date: 2015-12-30 Impact factor: 9.910
Authors: James F Toole; M René Malinow; Lloyd E Chambless; J David Spence; L Creed Pettigrew; Virginia J Howard; Elizabeth G Sides; Chin-Hua Wang; Meir Stampfer Journal: JAMA Date: 2004-02-04 Impact factor: 56.272
Authors: Karl C Desch; Ayse B Ozel; David Siemieniak; Yossi Kalish; Jordan A Shavit; Courtney D Thornburg; Anjali A Sharathkumar; Caitlin P McHugh; Cathy C Laurie; Andrew Crenshaw; Daniel B Mirel; Yoonhee Kim; Cheryl D Cropp; Anne M Molloy; Peadar N Kirke; Joan E Bailey-Wilson; Alexander F Wilson; James L Mills; John M Scott; Lawrence C Brody; Jun Z Li; David Ginsburg Journal: Proc Natl Acad Sci U S A Date: 2012-12-24 Impact factor: 11.205
Authors: Stephen R Williams; Qiong Yang; Fang Chen; Xuan Liu; Keith L Keene; Paul Jacques; Wei-Min Chen; Galit Weinstein; Fang-Chi Hsu; Alexa Beiser; Liewei Wang; Ebony Bookman; Kimberly F Doheny; Philip A Wolf; Michelle Zilka; Jacob Selhub; Sarah Nelson; Stephanie M Gogarten; Bradford B Worrall; Sudha Seshadri; Michèle M Sale Journal: PLoS Genet Date: 2014-03-20 Impact factor: 5.917
Authors: Nina Buchtele; Michael Schwameis; James C Gilbert; Christian Schörgenhofer; Bernd Jilma Journal: Thromb Haemost Date: 2018-05-30 Impact factor: 5.249
Authors: Katarina D Kovacevic; Stefan Greisenegger; Agnes Langer; Georg Gelbenegger; Nina Buchtele; Ingrid Pabinger; Karin Petroczi; Shuhao Zhu; James C Gilbert; Bernd Jilma Journal: Sci Rep Date: 2021-02-04 Impact factor: 4.379